Facilities

Clinical Research Unit

Opened in the fall of 2011, the new Clinical Research Unit of the ADI is located on the second floor of the Li Ka Shing Centre for Health Research Innovation. It is an 8000 ft2 facility with infrastructure capable of supporting medical phase trials, as well as amenitites that support nutritional, body composition and metabolic studies. The Clinical Research Unit serves as a place where basic and clinical scientists work together to perform studies that incorporate translational research (the process of making research findings benefit patients) resulting in meaningful health outcomes. The Clinical Research Unit, along with skilled researchers and coordinators, will provide a welcoming and proficient setting for participants to volunteer in ground breaking research studies. The addition of this world class facility to the ADI promises to hold exciting outcomes for all of those involved.

Download Brochure 

 

Alberta Cell Therapy Manufacturing (ACTM)

Cell and Tissue Innovation Research CentreThe Alberta Diabetes Institute is excited to partner with the future Alberta Cell Therapy Manufacturing. Located in the Li Ka Shing Centre for Health Research Innovation, this  $26.2 million facility is currently under construction and is expected to begin operations in 2014.  The facility is a current good manufacturing practice (cGMP) compliant facility dedicated to the production of cells and tissues for therapeutic application.  The 10,000 ft2 facility will have one physically isolated cell processing room (yellow) with its own air handling system, solely dedicated to isolation of neonatal porcine islets. There are 5 other processing rooms for human stem cell programs (pink) and a support area (blue) for QA/QC laboratory testing for cGMP compliance prior to release of cGMP material from the facility. In addition, the support area (grey) has offices for personnel who will be responsible for operating and maintaining the facility under cGMP conditions.  For more information, click here.

 

 

Physical Activity and Diabetes Laboratory (PADL)

More people with diabetes are now working up a sweat, thanks to the Alberta Diabetes Institute’s Physical Activity and Diabetes Laboratory (PADL).

Physical activity plays a key role in the management of diabetes.  It improves insulin sensitivity, helps control blood glucose levels and can prevent or delay the onset of type 2 diabetes.  The PADL provides an ideal setting for researchers to study the benefits of physical activity in preventing and managing diabetes and related conditions.

The PADL combines a fully equipped fitness facility with a state-of-the-art exercise physiology and behavior assessment lab. The equipment is being used by people with diabetes (about 5 percent of the population) and people with conditions related to diabetes such as pre-diabetes, metabolic syndrome, polycystic ovary syndrome, obesity, etc. (these can affect about 30-40 percent of the population).

“The PADL’s mission is threefold,” says Dr. Normand Boulé, who is heading the program. “First, research:  volunteers from the community exercise in a supervised and controlled setting, so that we can measure the results. Second, education:  students, health care providers and exercise specialists learn how to prescribe and promote physical activity for their clients. And, third, community service:  the PADL is a place for people with diabetes to begin building physical activity into their lives. They can start out here before moving on to regular fitness centres in the wider community.”  The PADL was made possible by a commitment from the Flaman Group of Companies. The Saskatchewan-based retailer has pledged $125,000 towards the cost of fitness equipment.

For additional info, click here.